Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-038-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-11-24 through 2009-12-08
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study and GLP conform
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- according to §19b Abs. 1 Chemikaliengesetz (issued 30th march 2009)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., 5960 AD Horst / The Netherlands
- Age at study initiation: 8 - 12 wks
- Weight at study initiation: 19 - 22 g
- Housing: single caging, Makrolon Type II cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: =< 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +- 2
- Humidity (%): 45 - 65
- Photoperiod (hrs dark / hrs light): 12 / 12 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50, and 100 %
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: not specified (solution or dispersion)
- Irritation: no signs of irritation or systemic toxicity at 50 and 100 % ( 1 h and 24 +-4 h p.a.)
- Lymph node proliferation response: not determined in the pre-test
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response:
Stimulation index (SI) is ≥ 3
Response increases in dose-related manner
Criteria for irritation potential: The top dose is the highest technically achievable concentration whilst avoiding systemic toxicity and
excessive local irritation. No severe irritant effects were tolerated choosing the test concentrations.
Note: Ear weight or ear thickness were not determined.
TREATMENT PREPARATION AND ADMINISTRATION:
Days 1-3: 25 µL test suspension over an area of ~8 mm in diameter, 1x on day 1, 2, and 3
Days 4 and 5: no treatment
Day 6: Injection of 250 μL of 3H-methyl thymidine solution into all test and control mice via the tail vein. Five hours later, the animals were killed. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Calculation of mean values and standard deviations
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- - test concentration 25%: SI = 3.6 - 50% : SI = 7.23 - 100%: SI = 7.83 The EC3 value could not be calculated, since all Stimulation indices are above 3. But it can be estimated that EC3 is in the range of 20 %. Based on test results, no conclusion can be drawn about the sensitisation potential at lower concentrations.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Table 1 below
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test item n/i-C13-C15 aldehyde was found to be a skin sensitiser in a valid LLNA assay according to OECD TG 429 and conform to GLP.
- Executive summary:
n/i-C13 -C15 -Aldehyde was examined for contact allergenic potential in a Local Lymph node Assay (LLNA) that was conducted under GLP conditions and in accordance with OECD TG 429. Three groups each of four female mice were treated daily with the test item at concentrations of 25, 50, and 100% (w/v) in acetone:olive oil (4+1) by topical application of 25 µL to the dorsum of each ear lobe (left and right) for three consecutive days. A control group of four mice was treated with the vehicle only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a scintillation counter.
All treated animals survived the scheduled study period and no systemic signs of toxicity were observed. 24 hours after the second and 1 hour after the third application swelling and redness of the ears of all four animals of the highest concentration (100%) was observed. These local signs of irritation resolved until the day of preparation (day 6). The incorporation of thymidine was increased in all treated groups. Stimulation Indices of 3.60, 7.23, and 7.83 were determined with the test item at concentrations of 25, 50, and 100% in acetone:olive oil (4+1). The EC3 value could not be calculated, since all obtained SI´s were above 3. But it can be estimated that the EC3 values is in the range of 20%.
Based on the test results n/i-C13 -C15 -Aldehyde is considered a skin sensitizer in the LLNA. The study is considered to be valid and useful for assessment (Harlan, 2009).
Reference
Table 1: Calculation and Results of Individual Data
Test item concentration % (w/v) |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM minus - BGa) |
number of lymph nodes |
mean DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
14 |
--- |
--- |
--- |
--- |
--- |
BG II |
15 |
--- |
--- |
--- |
--- |
--- |
1 |
1014 |
1000 |
8 |
124.9 |
|
25 |
2 |
3608 |
3594 |
8 |
449.2 |
3.60 |
50 |
3 |
7243 |
7229 |
8 |
903.6 |
7.23 |
100 |
4 |
7843 |
7829 |
8 |
978.6 |
7.83 |
BG = Background (1 ml 5% trichloroacetic acid) in duplicate
1 = Control Group
2 - 4 = Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined
by dividing the measured value by the number of lymph nodes pooled.
Irritation potential:
24 hours after the second and 1 hour after the third application swelling and redness of the ears of all four animals of the highest concentration (100%) was observed. These local signs of irritation resolved until the day of preparation (day 6).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
n/i-C13 -C15 -aldehyde was examined for contact allergenic potential in a Local Lymph node Assay (LLNA) that was conducted under GLP conditions and in accordance with the OECD TG 429. Three groups each of four female mice were treated daily with the test item at concentrations of 25, 50, and 100% (w/v) in acetone:olive oil (4+1) by topical application of 25 µL to the dorsum of each ear lobe (left and right) for three consecutive days. A control group of four mice was treated with the vehicle only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a scintillation counter.
All treated animals survived the scheduled study period and no systemic signs of toxicity were observed. 24 hours after the second and 1 hour after the third application swelling and redness of the ears of all four animals of the highest concentration (100%) was observed. These local signs of irritation resolved until the day of preparation (day 6). The incorporation of thymidine was increased in all treated groups. Stimulation Indices of 3.60, 7.23, and 7.83 were determined with the test item at concentrations of 25, 50, and 100% in acetone:olive oil (4+1). The EC3 value could not be calculated, since all obtained SI´s were above 3. But it can be estimated that the EC3 values is in the range of 20%.
Based on the test results n/i-C13 -C15 -Aldehyde is considered a skin sensitizer in the LLNA. The study is considered to be valid and useful for assessment (Harlan, 2009).
n/i-C13 -C15 -aldehyde is, however, considered to be a weak skin sensitiser because the SI of 3.6 was only seen with a high concentration (25%) of the test material. And in a valid Human Repeated Insult Patch Test (HRIPT) no skin irritation or sensitisation was seen in the 104 male and female participants (age: 17 to 78 years) with the test material at a concentration of 10% (Consumer Product Testing Co., 2006).
Thus, n/i-C13 -C15 -aldehyde is a weak sensitiser.
Migrated from Short description of key information:
n/i-C13-15-aldehyde was a weak sensitiser in a valid Local Lymph Node Assay, with a stimulation index (S.I.) of 3.6 at a concentration of 25 %. No sensitisation was seen in a valid human patch test (concentration 10%; 104 participants) which confirms the weak allergenic potential.
Justification for selection of skin sensitisation endpoint:
OECD TG study in accordance with GLP (high reliability, Klimisch score 1)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Justification for selection of respiratory sensitisation endpoint:
No required endpoint according to Regulation (EC) No 1907/2006.
Justification for classification or non-classification
Based on the results obtained in a valid Local Lymph Node Assay the submission substance has to be classified as Skin sensitiser category 1B according to the criteria set in Regulation (EC) No 1272/2008 (including 2nd amendment; i.e. Regulation (EU) No 286/2011).
According to section 3.4.2.2.4.2 of the same regulation classification is required despite the negative Human Patch Test result.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.